| BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE |
218766 |
003 |
ANDA |
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE |
TABLET |
25MG |
No
|
No
|
2025/10/14
(TA)
|
--
|
CIPLA LTD |
None (Tentative Approval) |
| BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE |
218766 |
004 |
ANDA |
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE |
TABLET |
30MG |
No
|
No
|
2025/10/14
(TA)
|
--
|
CIPLA LTD |
None (Tentative Approval) |
| BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE |
218766 |
005 |
ANDA |
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE |
TABLET |
120MG |
No
|
No
|
2025/10/14
(TA)
|
--
|
CIPLA LTD |
None (Tentative Approval) |
| BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE |
218766 |
006 |
ANDA |
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE |
TABLET |
15MG |
No
|
No
|
2025/10/14
(TA)
|
--
|
CIPLA LTD |
None (Tentative Approval) |